Understanding OUR Cytokine-Based Immunotherapy Candidates Our motivation extends to advancing a robust portfolio of programs directed at growing the horizons of cytokine-based immunotherapy, specifically for cancers where procedure options remain limited. Use the links below to learn additional about our portfolio of cytokine-based immunotherapy candidates. Take a look at https://financefeeds.com/dogecoin-price-prediction-why-doge-is-a-better-bet-than-ada-but-may-struggle-to-outperform-rtx-in-2025/